Showing results (2341-2350 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 29, 2022
Incidence, Clinical Characteristics, and Predictors of Cardiovascular Immune-Related Adverse Events Associated with Immune Checkpoint InhibitorsTsuyoshi Isawa, Yukihiro Toi, Shunichi Sugawara, et al.
The Oncologist|March 29, 2022
Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint InhibitorsHyo Jung Park, Lei Qin, Ziad Bakouny, et al.
The Oncologist|March 29, 2022
Inequity in Telemedicine Use Among Patients with Cancer in the Deep South During the COVID-19 PandemicConnie C Shao, M Chandler McLeod, Lauren T Gleason, et al.
The Oncologist|April 15, 2022
Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and CorrelatesJulia Stal, Serena Y Yi, Sally Cohen-Cutler, et al.
The Oncologist|September 8, 2018
"I need to know what makes somebody tick …": Challenges and Strategies of Implementing Shared Decision-Making in Individualized OncologyJoschka Haltaufderheide, Sebastian Wäscher, Bernhard Bertlich, et al.
The Oncologist|August 31, 2018
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II StudyLiwen Xiong, Rong Li, Jiayuan Sun, et al.
The Oncologist|September 2, 2018
The Role of Primary Care Physicians in Childhood Cancer Survivorship Care: Multiperspective InterviewsChristina Signorelli, Claire E Wakefield, Joanna E Fardell, et al.
The Oncologist|September 2, 2018
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast CancerKathleen Van Asten, Laurence Slembrouck, Siel Olbrecht, et al.
The Oncologist|September 2, 2018
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin AnalogsBarbara Kiesewetter, Heying Duan, Wolfgang Lamm, et al.
The Oncologist|August 18, 2018
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic MastocytosisYvette L Kasamon, Chia-Wen Ko, Sriram Subramaniam, et al.
Pageof 571